How Do I File an ERCP Infection Lawsuit?

If you are searching for how to file an ERCP infection lawsuit, you are likely dealing with a difficult recovery and many unanswered questions. People often want to know whether they can qualify, what proof is needed, and how fast they must act. This guide explains the process in practical terms so you can move forward with clearer next steps.

ERCP (endoscopic retrograde cholangiopancreatography) is used to diagnose and treat problems in the bile and pancreatic ducts. While ERCP can be medically necessary, some patients later experience serious infections and complications. In certain situations, legal claims may investigate whether device contamination, reprocessing problems, warning issues, or other failures contributed to harm.

What Is an ERCP Infection Lawsuit?

An ERCP infection lawsuit is a legal claim alleging that a patient suffered a serious infection or related injury connected to an ERCP procedure and that responsible parties may be liable. Depending on the facts, claims may involve product liability, negligence, or failure-to-warn allegations.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

Not every post-procedure complication creates a valid case. A claim usually depends on documented harm, evidence, and timing under state law.

Step 1: Build a Clear Timeline

Begin by organizing the sequence of events from procedure to diagnosis.

Include:

• Date of ERCP
• Facility and provider information
• Date symptoms began
• ER visits, admissions, and discharge dates
• Infection diagnosis and test dates
• Treatments received (including antibiotics or additional procedures)
• Ongoing complications

A structured timeline helps screening teams quickly evaluate whether your case may fit current criteria.

Step 2: Gather Core Medical Records

Your records are often the foundation of any meaningful legal review.

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

Try to collect:

• ERCP procedure report
• Hospital discharge summary
• Lab and culture results
• Imaging reports
• Infectious disease consults
• Follow-up treatment records
• Readmission paperwork
• Billing and insurance documentation

If your file is incomplete, start anyway. A review team can often identify the highest-priority records to request next.

Step 3: Document Financial and Personal Impact

Compensation analysis often includes both medical costs and life impact.

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

FDA safety communications in 2015 and 2019 noted that certain Olympus TJF-Q180V duodenoscopes could harbor bacteria even after following manufacturer reprocessing instructions—a central theme in coordinated infection litigation.

Track:

• Lost wages and time away from work
• Out-of-pocket treatment costs
• Travel expenses for care
• Pain and functional limitations
• Home-care needs or caregiver time
• Long-term health effects

Accurate notes can make later case evaluation more efficient and credible.

Step 4: Confirm Who Can File the Claim

In many cases, the injured person files directly. If the patient cannot file, a legal representative may be able to act on their behalf. If the patient passed away, wrongful death rules may apply depending on state law.

FDA safety communications in 2015 and 2019 noted that certain Olympus TJF-Q180V duodenoscopes could harbor bacteria even after following manufacturer reprocessing instructions—a central theme in coordinated infection litigation.

Common intake questions include:

• Who has authority to sign and act?
• Is there existing representation for this same claim?
• Which state's law is likely to control the filing?

These issues are normal and help determine the correct legal pathway.

Step 5: Check Statutes of Limitations Immediately

Time limits are critical. Missing the filing deadline can bar recovery, even in serious injury cases.

FDA safety communications in 2015 and 2019 noted that certain Olympus TJF-Q180V duodenoscopes could harbor bacteria even after following manufacturer reprocessing instructions—a central theme in coordinated infection litigation.

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

Deadline rules may depend on:

• State law
• Discovery date of injury
• Claim type (injury vs. wrongful death)
• Potential tolling exceptions

Because these rules vary, early eligibility review is usually the safest move.

Step 6: Request a Free Eligibility Check

Most people begin with a screening before any formal filing decision. Screening helps determine whether your facts and records match current legal intake criteria.

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

For a free eligibility check, visit ScopeInfection.com to see if you are eligible for compensation.

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

The review typically focuses on:

• ERCP procedure details
• Severity and timing of infection
• Available clinical documentation
• Current legal screening requirements

Step 7: What Happens After Screening

If your case appears eligible, a law firm may conduct deeper review of records, causation questions, and damages. The legal team can then decide whether and where to file.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

Typical phases may include:

1. Initial intake and screening
2. Attorney review
3. Medical record development
4. Filing and litigation planning
5. Negotiation or trial track

According to peer-reviewed endoscopy literature, duodenoscope-associated outbreaks declined after institutions adopted culture-and-quarantine surveillance, but litigation focuses on earlier periods when protocols varied.

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

Some claims settle, while others proceed through extended litigation. Outcomes vary with evidence and law.

Evidence That May Strengthen an ERCP Infection Claim

The strongest cases are usually supported by objective records.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

Helpful evidence may include:

• Positive cultures and infection diagnostics
• Clinical notes tying complications to post-ERCP events
• Procedure records showing scope use details
• Facility communications about infection events (if available)
• Expert analysis coordinated by counsel

Even if you only have partial records, you can still start with eligibility screening.

Potential Compensation Categories

If a claim is successful, damages may include:

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

• Medical expenses
• Lost wages and earning capacity impacts
• Pain and suffering
• Future treatment costs
• Other legally available damages by jurisdiction

Compensation is not guaranteed and depends on proof, injury facts, and applicable law.

Mistakes to Avoid

Avoid these common issues:

• Delaying your initial review
• Losing records or bills
• Depending only on memory instead of a written timeline
• Assuming no case without complete documents
• Publicly sharing sensitive claim strategy details

Prompt, organized action often gives you the best chance to preserve options.

Frequently Asked Questions

Do I need full proof before I request a screening?

No. Screening is designed to determine whether further investigation may be appropriate. You do not need to complete legal analysis by yourself first.

What if I do not know the exact device details?

You can still start. Those details are often clarified during records review.

Is the eligibility check free?

Yes, the eligibility check referenced here is free. Visit ScopeInfection.com to get a free check and see if you are eligible for compensation.

Can a family member pursue a claim after a death?

Potentially, yes. Wrongful death and estate authority rules vary by state and should be reviewed with counsel.

Final Checklist

If you are ready to take action:

• Build your ERCP timeline
• Gather available records and bills
• Document missed work and costs
• Request a free eligibility check
• Ask about state filing deadlines

Starting an eligibility review does not force you into a lawsuit. It helps you understand whether legal options may exist and whether compensation could be available for your circumstances.

According to CDC outbreak investigations, carbapenem-resistant *Enterobacteriaceae* (CRE) linked to contaminated duodenoscopes caused hospital outbreaks at multiple U.S. centers between 2012 and 2015, prompting FDA safety communications.

The FDA estimated in 2015 that more than 500,000 ERCP procedures are performed in the United States each year—procedures that rely on duodenoscopes with complex elevator-channel designs that are difficult to reprocess.

FDA safety communications in 2015 and 2019 noted that certain Olympus TJF-Q180V duodenoscopes could harbor bacteria even after following manufacturer reprocessing instructions—a central theme in coordinated infection litigation.

Top Tier Legal, LLC is not a law firm and does not provide legal advice. This content is for informational purposes only. Submitting information does not create an attorney-client relationship. If you qualify, Top Tier Legal, LLC may connect you with an independent law firm. Past results do not guarantee future outcomes.